Olmetec 40mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Buy It Now

Active ingredient:

Olmesartan medoxomil

Available from:

Dowelhurst Ltd

ATC code:

C09CA08

INN (International Name):

Olmesartan medoxomil

Dosage:

40mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02050502

Patient Information leaflet

                                OLMETEC 40MG FILM-COATED TABLETS
(olmesartan medoxomil)
PATIENT INFORMATION LEAFLET
Your medicine is known as Olmetec 40mg Film-coated Tablets but will be
referred to as Olmetec throughout the leaflet. Please note that the
leaflet
also contains information about other strengths of the medicine,
Olmetec
10mg Tablets and Olmetec 20mg Tablets
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor or pharmacist.
*
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.
*
If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
What Olmetec is and what it is used for
What you need to know before you take Olmetec
How to take Olmetec
Possible side effects
How to store Olmetec
Contents of the pack and other information
WHAT OLMETEC IS AND WHAT IT IS USED FOR
Olmetec belongs to a group of medicines called angiotensin-II receptor
antagonists. They lower blood pressure by relaxing the blood vessels.
Olmetec is used for the treatment of high blood pressure (also known
as
‘hypertension’) in adults and in children and adolescents aged 6
to less
than 18 years. High blood pressure can damage blood vessels in organs
such as the heart, kidneys, brain and eyes. In some cases this may
lead to a heart attack, heart or kidney failure, stroke or blindness.
Usually
high blood pressure has no symptoms. It is important to have your
blood pressure checked to prevent damage occurring.
High blood pressure can be controlled with medicines such as Olmetec
tablets. Your doctor has probably also recommended that you make
some changes in your lifestyle to help lower your blood pressure (for
example losing weight, giving up smoking, reducing the amount of
alcohol
you d
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Not applicable
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Not applicable
3.
PHARMACEUTICAL FORM
Not applicable
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Not applicable
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Not applicable
4.3.
CONTRAINDICATIONS
Not applicable
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not applicable
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Not applicable
4.6.
PREGNANCY AND LACTATION
Not applicable
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8.
UNDESIRABLE EFFECTS
Not applicable
4.9.
OVERDOSE
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Not applicable
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable
5.3.
PRECLINICAL SAFETY DATA
Not applicable
6.
PHARMACEUTICAL PARTICULARS
6.1.
LIST OF EXCIPIENTS
Not applicable
6.2.
INCOMPATIBILITIES
Not applicable
6.3.
SHELF LIFE
Not applicable
6.4.
SPECIAL PRECAUTIONS FOR STORAGE
Not applicable
6.5.
NATURE AND CONTENTS OF CONTAINER
Not applicable
6.6.
INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL)
Not applicable
ADMINISTRATIVE DATA
7.
MARKETING AUTHORISATION HOLDER
Not applicable
8.
MARKETING AUTHORISATION NUMBER
Not applicable
9.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Not applicable
10.
DATE OF REVISION OF THE TEXT
Not applicable
                                
                                Read the complete document
                                
                            

Search alerts related to this product